Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Capital Expenditures (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Capital Expenditures for 14 consecutive years, with -$2192.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Capital Expenditures fell 144.67% year-over-year to -$2192.0, compared with a TTM value of $7099.0 through Dec 2024, down 97.24%, and an annual FY2024 reading of $250867.0, down 73.4% over the prior year.
  • Capital Expenditures was -$2192.0 for Q1 2025 at Aethlon Medical, down from $2192.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $739165.0 in Q3 2022 and bottomed at -$2192.0 in Q1 2025.
  • Average Capital Expenditures over 5 years is $103228.0, with a median of $38374.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures surged 3944.91% in 2022, then tumbled 144.67% in 2025.
  • Year by year, Capital Expenditures stood at $57934.0 in 2021, then surged by 161.48% to $151486.0 in 2022, then crashed by 94.19% to $8807.0 in 2023, then tumbled by 75.11% to $2192.0 in 2024, then tumbled by 200.0% to -$2192.0 in 2025.
  • Business Quant data shows Capital Expenditures for AEMD at -$2192.0 in Q1 2025, $2192.0 in Q4 2024, and $4907.0 in Q1 2024.